SHARE NOW
Bloomberg Intelligence’s Ann-Hunter van Kirk discusses one of the major topics addressed at Advanced Therapies Europe 2023, focusing on supporting biotech start-ups with finances and investment strategies for overcoming fundamental challenges within the cell and gene therapy space.
In this insightful video, Ann-Hunter van Kirk, Senior Equity Research Analyst at Bloomberg Intelligence, delves into the fundamental challenges and strategies biotech start-ups in the cell and gene industry should consider, including the pivotal topic of biotech funding and investment strategies.
Highlighting the unique challenges that biotech start-ups face when seeking funding and investment, Ann-Hunter explores how innovative strategies can serve as effective tools to mitigate these challenges, emphasizing the crucial balance between innovation and risk management when presenting proposals to potential investors.
Additionally, the interview provides valuable guidance on creating persuasive investment proposals, adhering to regulations, and protecting intellectual property for biotech startups.
This interview was recorded as part of Advanced Therapies Europe 2023.
While we have you…
We are continuously working to better optimize our content for you, our audience. Let us know how we’re doing by ticking the box below, or send us your feedback directly to team@phacilitate.com.
